We are live on
!
Find out more
MJP
Michael J. Puzo Portfolio holdings
AUM
$343M
1-Year Est. Return
18.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.68%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$361M
AUM Growth
+$45.9M
(+15%)
Cap. Flow
+$17.7M
Cap. Flow
% of AUM
4.91%
Top 10 Holdings %
Top 10 Hldgs %
40.06%
Holding
78
New
3
Increased
35
Reduced
27
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ball Corp
BALL
|
+$1.82M |
| 2 |
Carrier Global
CARR
|
+$1.81M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$1.59M |
| 4 |
Johnson & Johnson
JNJ
|
+$1.12M |
| 5 |
Amazon
AMZN
|
+$959K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$3.05M |
| 2 |
CVS Health
CVS
|
+$1.13M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$594K |
| 4 |
NVIDIA
NVDA
|
+$400K |
| 5 |
Honeywell
HON
|
+$369K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.47% |
| 2 | Healthcare | 21.49% |
| 3 | Industrials | 12.76% |
| 4 | Consumer Discretionary | 10.34% |
| 5 | Financials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Colgate-Palmolive
CL
$74.6B
| $525K | 0.15% |
5,830
-560
| -9% | -$47.4K |
|
52
Ecolab
ECL
$78.8B
| $514K | 0.14% |
2,225
| – | – |
|
53
Sysco
SYY
$41B
| $488K | 0.14% |
6,015
+965
| +19% | +$76K |
|
54
Bank OZK
OZK
$5.63B
| $394K | 0.11% |
8,675
-760
| -8% | -$34K |
|
55
Dover
DOV
$26.9B
| $390K | 0.11% |
2,200
| – | – |
|
56
Nucor
NUE
$58.3B
| $356K | 0.1% |
1,800
| – | – |
|
57
Bank of Montreal
BMO
$124B
| $342K | 0.09% |
3,500
| – | – |
|
58
American Express
AXP
$226B
| $342K | 0.09% |
1,500
-100
| -6% | -$20.7K |
|
|
59
Honeywell
HON
$76.9B
| $339K | 0.09% |
1,755
-1,961
| -53% | -$369K |
|
60
Bristol-Myers Squibb
BMY
$130B
| $331K | 0.09% |
6,100
-550
| -8% | -$28K |
|
61
Adobe
ADBE
$105B
| $321K | 0.09% |
637
+299
| +88% | +$171K |
|
62
Edwards Lifesciences
EW
$49B
| $320K | 0.09% |
3,350
-2,250
| -40% | -$189K |
|
63
Wells Fargo
WFC
$257B
| $290K | 0.08% |
5,000
| – | – |
|
64
Texas Instruments
TXN
$251B
| $287K | 0.08% |
1,650
-150
| -8% | -$25K |
|
65
Paychex
PAYX
$44B
| $282K | 0.08% |
2,300
-115
| -5% | -$14K |
|
66
Alphabet (Google) Class C
GOOG
$4.1T
| $277K | 0.08% |
1,820
-40
| -2% | -$5.77K |
|
67
Coca-Cola
KO
$385B
| $245K | 0.07% |
4,000
| – | – |
|
68
Idexx Laboratories
IDXX
$45B
| $216K | 0.06% |
400
| – | – |
|
69
Cisco
CSCO
$451B
| – | – |
-4,100
| Closed | -$207K |
|
70
Gilead Sciences
GILD
$167B
| – | – |
-2,600
| Closed | -$211K |
|
71
Pfizer
PFE
$144B
| – | – |
-12,755
| Closed | -$367K |
|
Similar funds
WP
LWM
CWM
BA
TCMNY
FMB
AWA
FCM
Michael J. Puzo's Q1 2024 Portfolio in Review
As of Q1 2024, Michael J. Puzo held 78 positions worth $361M, up 15% from $315M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Michael J. Puzo deployed $17.7M of net new capital in Q1 2024, opening 3 new positions and adding to 35 existing holdings. Its largest new stake was Ball Corp: 29,868 shares worth $2.01M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Novartis, an estimated $3.05M trimmed.
- Michael J. Puzo's largest Q1 2024 buy was Ball Corp: 29,868 shares worth $2.01M.
- Michael J. Puzo added most to Vertex Pharmaceuticals in Q1 2024, an estimated $1.59M increase.
- Michael J. Puzo's biggest Q1 2024 reduction was Novartis, cutting an estimated $3.05M.
- Michael J. Puzo fully exited Pfizer in Q1 2024, selling an estimated $367K.
- Michael J. Puzo's ten largest holdings make up 40% of its $361M portfolio in Q1 2024.
- Michael J. Puzo opened 3 new positions and closed 3 in Q1 2024.
- Michael J. Puzo's portfolio value rose 15% quarter-over-quarter to $361M.
Based on Michael J. Puzo's 13F filing for Q1 2024, filed 13 May 2024.